MedTrace Logo

Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

NCT01729559 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 495

Last updated 2016-07-18

Study results available
· View outcomes & findings →

Summary

The rate of venous thromboembolic events in trauma patients at high risk for deep vein thrombosis and pulmonary embolism receiving low dose unfractionated heparin every 8 hours will be equivalent or less than a similar group of patients given a standard every 12 hour dose of low molecular weight heparin.

Conditions

Interventions

DRUG

5000 Units unfractionated Heparin Q 8 hr

Venous thromboembolic prophylaxis medication

DRUG

30mg enoxaparin Q12 hr

Venous thromboembolic prophylaxis

Sponsors & Collaborators

  • Scripps Health

    lead OTHER

Principal Investigators

  • Steven R Shackford, MD · Scripps Mercy Hospital, Department of Trauma Surgery

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-09-30
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01729559 on ClinicalTrials.gov